Takeshi Yamamura Selected Research

Takeshi Yamamura Research Topics

Disease

15	Crohn Disease (Crohn's Disease) 05/2024 - 01/2016
13	Pathologic Constriction (Stenosis) 03/2024 - 01/2015
9	Ulcerative Colitis 12/2023 - 12/2020
9	Hemorrhage 11/2023 - 08/2014
7	Neoplasms (Cancer) 09/2023 - 09/2014
6	Colitis 05/2024 - 03/2016
5	Polyps 10/2020 - 12/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 10/2016
3	Ulcer 01/2023 - 03/2016
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2024 - 06/2021
2	Syncope (Fainting) 09/2022 - 03/2022
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2020 - 01/2020
2	Pain (Aches) 01/2020 - 11/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018 - 03/2016
1	Body Weight (Weight, Body) 05/2024
1	Necrosis 12/2023
1	Peptic Ulcer (Peptic Ulcers) 07/2023
1	Duodenal Ulcer (Curling's Ulcer) 07/2023
1	Immunoproliferative Small Intestinal Disease 09/2022
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2022
1	Adenocarcinoma 07/2022
1	Cholangitis 07/2022
1	Esophageal Stenosis (Esophageal Stricture) 05/2022
1	Esophageal Neoplasms (Esophageal Cancer) 05/2022
1	Autoimmune Diseases (Autoimmune Disease) 04/2022
1	Sarcopenia 04/2022
1	Hematemesis 03/2022
1	Diarrhea 11/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Hirschsprung Disease (Hirschsprung's Disease) 12/2020
1	Lymphatic Metastasis 06/2020
1	Heart Failure 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

18	Capsules (Microcapsules)IBA 10/2023 - 08/2014
7	Biomarkers (Surrogate Marker)IBA 07/2023 - 09/2014
5	Ustekinumab (CNTO 1275)FDA Link 10/2023 - 10/2020
3	AntibodiesIBA 05/2024 - 11/2021
3	CytokinesIBA 05/2024 - 10/2016
3	InterleukinsIBA 05/2024 - 10/2016
3	AnticoagulantsIBA 11/2023 - 09/2022
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2016
2	Interleukin-18 (Interleukin 18)IBA 05/2024 - 12/2023
2	Monoclonal AntibodiesIBA 05/2024 - 12/2023
2	C-Reactive ProteinIBA 10/2023 - 04/2022
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 07/2023 - 05/2018
2	Glycoproteins (Glycoprotein)IBA 07/2023 - 01/2023
2	Leucine (L-Leucine)FDA Link 07/2023 - 01/2023
2	NitrogenIBA 09/2022 - 03/2022
2	Urea (Carbamide)FDA LinkGeneric 09/2022 - 03/2022
2	Indicators and Reagents (Reagents)IBA 09/2022 - 04/2022
2	SteroidsIBA 05/2022 - 05/2014
2	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2021
2	LigandsIBA 01/2021 - 12/2018
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
2	HaptensIBA 01/2017 - 10/2016
1	CXC ChemokinesIBA 12/2023
1	Dextran SulfateIBA 12/2023
1	OccludinIBA 12/2023
1	InterferonsIBA 12/2023
1	CoagulantsIBA 11/2023
1	Warfarin (Coumadin)FDA LinkGeneric 09/2023
1	1-kestoseIBA 01/2023
1	PrebioticsIBA 01/2023
1	MaltoseIBA 01/2023
1	Interleukin-12 (IL 12)IBA 11/2022
1	Therapeutic UsesIBA 11/2022
1	Minocycline (Cyclops)FDA LinkGeneric 09/2022
1	CreatinineIBA 09/2022
1	GelsolinIBA 04/2022
1	tofacitinibIBA 02/2022
1	alpha-SynucleinIBA 01/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2021
1	Lugol's solution (Lugol's iodine)IBA 12/2020
1	vedolizumabIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Renin InhibitorsIBA 01/2020
1	imarikiren hydrochlorideIBA 01/2020
1	EnzymesIBA 01/2020
1	Scopolamine (Hyoscine)FDA Link 01/2020
1	NeodymiumIBA 01/2020
1	Parasympatholytics (Antispasmodics)IBA 01/2020
1	CalsequestrinIBA 01/2020
1	ReninIBA 01/2020

Therapy/Procedure

8	Therapeutics 12/2023 - 09/2014
5	Endoscopes 03/2024 - 11/2019
3	Surgical Instruments (Clip) 07/2023 - 02/2015
3	Lasers (Laser) 10/2020 - 04/2017
2	Ligation 02/2024 - 06/2021
1	Biological Therapy 05/2024
1	Blood Transfusion (Blood Transfusions) 07/2023
1	Endoscopic Hemostasis 07/2023
1	Sutures (Suture) 01/2023
1	Fecal Microbiota Transplantation 07/2022
1	Endoscopic Sphincterotomy 07/2022
1	Catheters 01/2022
1	Blood Component Removal (Apheresis) 12/2020
1	Aftercare (After-Treatment) 06/2020
1	Colectomy 01/2020